相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Normal life expectancy for polycythemia vera (PV) patients is possible
Ghaith Abu-Zeinah et al.
LEUKEMIA (2022)
Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b
Jean-Jacques Kiladjian et al.
LEUKEMIA (2022)
Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study inBCR-ABL1-negative myeloproliferative neoplasms (MPN)-on behalf of the German Study Group-MPN
Frank Stegelmann et al.
LEUKEMIA (2021)
Interferon alpha therapy in essential thrombocythemia and polycythemia vera-a systematic review and meta-analysis
Jan Philipp Bewersdorf et al.
LEUKEMIA (2021)
Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival
Ghaith Abu-Zeinah et al.
LEUKEMIA (2021)
Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow-up
Erik Ahlstrand et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial
Lucia Masarova et al.
LANCET HAEMATOLOGY (2017)
Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera
Cecilie Utke Rank et al.
LEUKEMIA & LYMPHOMA (2016)
Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations
Emmanuelle Verger et al.
BLOOD (2015)
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
Ayalew Tefferi et al.
BLOOD (2014)
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)
Tiziano Barbui et al.
BLOOD (2012)
Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
Tiziano Barbui et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference
Giovanni Barosi et al.
BLOOD (2009)
Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
Alfonso Quintas-Cardama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
分享论文
